قد يعجبك
Acalabrutinib versus investigator's choice therapy in chronic lymphocytic leukemia - the ASCEND trial fal.cn/38xA8 #CLL #leusm #JCO
In this double-blind, randomized trial, 821 asymptomatic persons with a high- or moderate-risk exposure to #SARSCoV2 were assigned to receive hydroxychloroquine or placebo within 4 days after the exposure. No benefit in preventing illness compatible with #COVID19 was found.
ADAURA Establishes Adjuvant Osimertinib as a New Standard of Care for Early-Stage EGFR-Mutated #NSCLC fal.cn/38oWV #ASCODailyNews #LBA #ASCO20 @DrRoyHerbstYale @dave6408
Presenting the ADAURA data now @ASCO @ASCOPost at the plenary session. #ASCO20 The primary endpoint was met with DFS HR=0.17! Thank you to all the coinvestigators, study team & patients for participating in this practice changing study! @AstraZeneca @YaleCancer @Yale @LungMAP
United States الاتجاهات
- 1. Brunson 6,608 posts
- 2. Knicks 11.8K posts
- 3. Jaylen Brown 5,364 posts
- 4. Celtics 12.2K posts
- 5. Duke 28K posts
- 6. #WWENXT 10.4K posts
- 7. Notre Dame 34K posts
- 8. Jordan Walsh N/A
- 9. Miami 95.2K posts
- 10. Bama 22.6K posts
- 11. Van Epps 126K posts
- 12. Tennessee 214K posts
- 13. Mikal Bridges 1,372 posts
- 14. Isaiah Evans 1,270 posts
- 15. Boogie Fland N/A
- 16. Nashville 33.4K posts
- 17. Behn 76.1K posts
- 18. Cam Boozer 1,029 posts
- 19. #RHOSLC 2,566 posts
- 20. Syracuse 8,770 posts
Something went wrong.
Something went wrong.